Navigation Links
Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Date:2/12/2008

een convened to offer

advice about the prospective analysis of the ENHANCE trial. (Announced

Nov. 19, 2007)

-- Reported on new study results that demonstrated that asenapine was more

effective than placebo and well tolerated in treating patients with

acute schizophrenia. (Announced Dec. 17, 2007)

-- Announced with Centocor, Inc., revision of a 1998 distribution

agreement regarding the development, commercialization and distribution

of both REMICADE (infliximab) and golimumab. (Announced Dec. 21, 2007)

-- Received priority review status from FDA for the company's New Drug

Application for sugammadex, an agent specifically designed to reverse

the effects of certain muscle relaxants used in surgery. Also announced

filing of an NDA with the Japanese Ministry of Health, Labor and

Welfare. (Announced Jan. 2, 2008, and Jan. 17, 2008, respectively)

-- Merck/Schering-Plough Pharmaceuticals announced the primary endpoint

and other results of the ENHANCE trial. Merck/Schering-Plough has

submitted an abstract on the ENHANCE trial for presentation at the

American College of Cardiology meeting, which will be held in March

2008. (Announced Jan. 14, 2008)

-- Reported top-line results of the IDEAL study, showing that sustained

virologic response was similar for the two leading combination

therapies for hepatitis C, and that fewer patients treated with both

PEGINTRON regimens relapsed after the end of treatment compared to

those receiving Pegasys and Copegus. (Announced Jan. 14, 2008)

-- Announced that Schering-Plough Chairman/CEO Fred Hassan intends to make

an open market purchase of $2 million of Schering-Plough Common Shares

with personal funds. (Announced Jan. 18, 2008)

-- With Merck, issued a release strongly objecting to mischaracterizations

of
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
2. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
3. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
4. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
5. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
6. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
9. Schering-Plough Completes Acquisition of Organon BioSciences
10. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
11. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... , Dec. 22, 2014 /PRNewswire/ - RepliCel Life ... regenerative medicine company focused on the development of autologous ... out of the University of Calgary in conjunction with ... Carolina, which further validates the company,s ongoing clinical research ... effects of pattern baldness. The paper entitled ...
(Date:12/22/2014)... , Dec. 22, 2014 GenomeDx Biosciences today ... Prostate Cancer Classifier, a genomic test for prostate cancer, ... high-risk men managed by radical prostatectomy without adjuvant therapy. ... is relatively uncommon, using tumor genomics to identify these ... disease is an important advance. The study has been ...
(Date:12/22/2014)... The American Journal of Hematology/Oncology, ... reviews and editorials addressing developments and pathways related ... a provocative article exploring the role of follicle-stimulating ... treatment of prostate cancer. , The article ... possibility that there could be a connection to ...
(Date:12/22/2014)... Fertility Associates of Memphis has announced ... , a network of more than 20 contributing ... have fast access to a national pool of frozen ... Fertility Associates of Memphis is the only fertility clinic ... , Dr. William Kutteh , director of Fertility ...
Breaking Biology Technology:Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3
... the Cingular merger with AT&T? , ,I've read the business ... acquires the assets and customers of AT&T Wireless for $41 ... No. 2 carrier Verizon by 9 million subscribers. The one ... Wireless brand and plans to launch a new wireless service ...
... movers will get a crash course in getting their foot ... Symposium on March 2 in the Fluno Center. , ... and produced in conjunction with WTN Media, will bring ... , ,I think its quite significant to CIOs, in terms ...
... U.S. during 2004. , ,We also took a look at ... well as how the life science industry performed. Though I had ... life science industry in the Midwest performed, that data is not ... was able to ferret out some additional data on venture capital ...
Cached Biology Technology:Cingular confusion 2Cingular confusion 3Fusion 2005 symposium aims to bring CIOs to the boardroom 2Midwest VC investment up in 2004, but number of deals down 2Midwest VC investment up in 2004, but number of deals down 3
(Date:12/22/2014)... , Dec. 22, 2014  NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... and security consultant, Apollo Robbins for the ... wallet.  Apollo Robbins will ... th , 2015, demonstrating some of his famous theft ...
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... of the "Micro Market Monitor: North America Perimeter ... http://photos.prnewswire.com/prnh/20130307/600769 The ... at a CAGR of 3.6% from 2014 to 2019. ... this market, Canada is expected ...
(Date:12/17/2014)... , Dec. 15, 2014 The Defense ... it easier to detect and prevent counterfeit microcircuits ... Today the agency started performing an in-house microcircuit ... validate the authenticity of purchased microcircuits while increasing ... quality control measures will be conducted at DLA,s ...
Breaking Biology News(10 mins):NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3
... out at the University of Gothenburg may lead to more ... resistant plants, and crops with a limited absorption and storage ... organs in the human body, it is used in the ... active component of drugs against parasitic diseases. Healing ...
... 25, 2012The tiniest and the heaviest fetuses are at much ... new research has found. , Fetuses who are "severely small ... of all fetuses, disproportionately account for about six per cent ... , Fetuses that are "severely large for gestational age," or ...
... The human gut is home to a teeming ecosystem ... and disease. But while the gut microbiota is interacting ... viruses. In a study published online in ... system, revealing a common set of viruses associated with gut ...
Cached Biology News:Arsenic for better drugs and cleaner crops 2Smallest and largest fetuses at greater risk of being stillborn, research finds 2Gut microbes battle a common set of viruses shared by global populations 2
... PCR plate, Directly compatible with ABI thermal ... for improved sealing characteristics can be ... or cap strips, Certified free of DNase, ... part of Thermo Fisher Scientific, the world ...
AVOID FREEZE/THAW CYCLES. Recognizes the ~32 kDa DNase IIα chain and the ~40 kDa proenzyme. DNase II causes both DNA condensation and DNA fragmentation. ...
BD BioCoat Vented Caps for 175 cm2 Flasks...
...
Biology Products: